Wealth Enhancement Advisory Services’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305K Buy
14,617
+2,911
+25% +$68.5K ﹤0.01% 3328
2026
Q2
$281K Buy
+11,706
New +$263K ﹤0.01% 3263
2024
Q1
– Sell
-11,244
Closed -$234K – 2510
2023
Q4
$234K Sell
11,244
-5,178
-32% -$99.4K ﹤0.01% 2001
2023
Q3
$354K Buy
+16,422
New +$399K ﹤0.01% 1636

Other funds holding FMS

Wealth Enhancement Advisory Services's FMS Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Fresenius Medical Care (FMS) stake by 25% in Q3 2026, buying an estimated $68.5K and bringing the position to 14,617 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Wealth Enhancement Advisory Services first reported a position in FMS in Q3 2023 and has held it in 4 quarters since. The position peaked at $354K in Q3 2023. 81 funds tracked by Wall St. Rank hold FMS as of Q3 2026.

  • Wealth Enhancement Advisory Services held 14,617 shares of Fresenius Medical Care worth $305K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 2,911 Fresenius Medical Care shares in Q3 2026, an estimated $68.5K.
  • Fresenius Medical Care made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3328 holding.
  • Wealth Enhancement Advisory Services first reported a position in Fresenius Medical Care in Q3 2023 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Fresenius Medical Care position peaked at $354K in Q3 2023.
  • 81 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.